Caribou Biosciences, Inc. — Form D

Caribou Biosciences, Inc. of BERKELEY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-03-05. The offering totals $115.0M, of which $115.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (20)

NameRoleLocation
Rachel E HaurwitzDirectorBerkeley, CA
Jeffrey G Long-McGieDirectorBerkeley, CA
Santhosh G PalaniDirectorBerkeley, CA
Natalie R SacksDirectorBerkeley, CA
Robert E WeisskoffDirectorBerkeley, CA
Rachel E HaurwitzExecutive OfficerBerkeley, CA
Steven B KannerExecutive OfficerBerkeley, CA
Barbara G McClungExecutive OfficerBerkeley, CA
Jason B O'ByrneExecutive OfficerBerkeley, CA
Robert WeisskoffDirectorFoster City, CA
Rodolphe BarrangouDirectorLONG ISLAND CITY, NY
Jenny RookeDirectorWaltham, MA
Andrew MayExecutive OfficerAltrincham, X0
Jenny E RookeDirectorBerkeley, CA
Rodolphe E BarrangouDirectorBerkeley, CA
Andrew P MayExecutive OfficerBerkeley, CA
Un G Kwon-CasadoExecutive OfficerBerkeley, CA
Philip E AustinDirectorBerkeley, CA
Rachel HaurwitzDirectorCAMBRIDGE, MA
Rachel HaurwitzExecutive OfficerCAMBRIDGE, MA

Other filings by this issuer (3)

FiledFormOfferingSold
2016-05-25D$30.1M$14.5M
2015-03-24D/A$11.5M$11.5M
2014-09-23D$5.2M$2.9M

More